Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ATRA

Atara Biotherapeutics

07:35
01/19/18
01/19
07:35
01/19/18
07:35
Recommendations
Atara Biotherapeutics analyst commentary  »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
ALXN

Alexion

$122.12

-2.36 (-1.90%)

08:59
01/18/18
01/18
08:59
01/18/18
08:59
Initiation
Alexion initiated at Credit Suisse »

Alexion assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ATRA

Atara Biotherapeutics

$19.35

0.8 (4.31%)

08:05
01/10/18
01/10
08:05
01/10/18
08:05
Hot Stocks
Atara reports FDA clearance to proceed with enrollment for Phase 1 trial »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTLA

Portola Pharmaceuticals

$47.99

-0.7 (-1.44%)

08:55
01/09/18
01/09
08:55
01/09/18
08:55
Conference/Events
Portola Pharmaceuticals to host a webcast »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 02

    Feb

  • 04

    May

ABLX

Ablynx

$38.62

12.71 (49.05%)

, NVO

Novo Nordisk

$54.69

-0.05 (-0.09%)

07:57
01/09/18
01/09
07:57
01/09/18
07:57
Recommendations
Ablynx, Novo Nordisk analyst commentary at Baird »

Ablynx bid a floor for…

ABLX

Ablynx

$38.62

12.71 (49.05%)

NVO

Novo Nordisk

$54.69

-0.05 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

ALXN

Alexion

$122.80

0.11 (0.09%)

12:20
01/08/18
01/08
12:20
01/08/18
12:20
Earnings
Alexion targets double digit revenue growth, faster earnings growth »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

ABLX

Ablynx

$25.91

0.85 (3.39%)

, NVO

Novo Nordisk

$54.74

0.25 (0.46%)

08:50
01/08/18
01/08
08:50
01/08/18
08:50
Recommendations
Ablynx, Novo Nordisk analyst commentary at Deutsche Bank »

Novo offer for Ablynx…

ABLX

Ablynx

$25.91

0.85 (3.39%)

NVO

Novo Nordisk

$54.74

0.25 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

QURE

uniQure

$19.48

-0.43 (-2.16%)

07:06
01/08/18
01/08
07:06
01/08/18
07:06
Hot Stocks
uniQure 'intensifying efforts to further expand' gene therapy product pipeline »

uniQure announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$54.74

0.25 (0.46%)

, ABLX

Ablynx

$25.91

0.85 (3.39%)

06:01
01/08/18
01/08
06:01
01/08/18
06:01
Hot Stocks
Novo Nordisk offers to acquire Ablynx for up to EUR30.50 per share in cash »

Novo Nordisk (NVO)…

NVO

Novo Nordisk

$54.74

0.25 (0.46%)

ABLX

Ablynx

$25.91

0.85 (3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

ALXN

Alexion

$124.95

0.9 (0.73%)

07:26
01/04/18
01/04
07:26
01/04/18
07:26
Downgrade
Alexion rating change  »

Alexion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.